Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study
Gloria Dalla Costa(Harvard University), Gıancarlo Comı(Casa di Cura Columbus), Ana Isabel Guerrero(Universitat Autònoma de Barcelona), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Letizia Leocani(Vita-Salute San Raffaele University), Per Soelberg Sørensen(University of Copenhagen), Richard Dobson(King's College London), Vaibhav A. Narayan(Janssen (United States)), Matthew Hotopf(King's College London), Nicholas Cummins(University of Augsburg), Melinda Magyari(University of Copenhagen)
Cited by 59
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science
|The Lancet Psychiatry|2020|6k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population
|The Lancet Psychiatry|2020|2.8k